Operating Lease, Right-of-Use Asset of LianBio from 31 Dec 2020 to 30 Sep 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of lessee's right to use underlying asset under operating lease.
Summary
LianBio quarterly Operating Lease, Right-of-Use Asset in USD history and change rate from 31 Dec 2020 to 30 Sep 2023.
  • LianBio Operating Lease, Right-of-Use Asset for the quarter ending 30 Sep 2023 was $2,644,000, a 39% decline year-over-year.
Source SEC data
View on sec.gov
Operating Lease, Right-of-Use Asset, Quarterly (USD)
Operating Lease, Right-of-Use Asset, YoY Quarterly Change (%)

LianBio Quarterly Operating Lease, Right-of-Use Asset (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q3 2023 $2,644,000 -$1,718,000 -39% 30 Sep 2023 10-Q 13 Nov 2023 2023 Q3
Q2 2023 $3,049,000 -$1,954,000 -39% 30 Jun 2023 10-Q 14 Aug 2023 2023 Q2
Q1 2023 $3,604,000 -$766,000 -18% 31 Mar 2023 10-Q 11 May 2023 2023 Q1
Q4 2022 $3,978,000 -$785,000 -16% 31 Dec 2022 10-Q 13 Nov 2023 2023 Q3
Q3 2022 $4,362,000 +$4,156,000 +2017% 30 Sep 2022 10-Q 10 Nov 2022 2022 Q3
Q2 2022 $5,003,000 30 Jun 2022 10-Q 11 Aug 2022 2022 Q2
Q1 2022 $4,370,000 31 Mar 2022 10-Q 12 May 2022 2022 Q1
Q4 2021 $4,763,000 +$3,057,000 +179% 31 Dec 2021 10-K 28 Mar 2023 2022 FY
Q3 2021 $206,000 30 Sep 2021 10-Q/A 10 Jan 2022 2021 Q3
Q4 2020 $1,706,000 31 Dec 2020 10-K 31 Mar 2022 2021 FY
* An asterisk sign (*) next to the value indicates that the value is likely invalid.